Skip to content

Postoperative Pain After Caesarian Section

Impact of Guideline Recommendations for Post-caesarean Analgesia on Pain, Nausea and Pruritus

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05659823
Enrollment
108
Registered
2022-12-21
Start date
2020-11-02
Completion date
2021-11-05
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consumption, Nausea and Vomiting Following Administration of Anaesthetic Agent, Pain, Postoperative, Pruritus

Brief summary

To examine if perioperative pain/nausea/pruritus is altered when current standard analgesia for caesarian section (CS) is replaced with new guideline recommended analgesia.

Detailed description

Control group (current analgesia, elective CS) is compared to current analgesia for emergency CS, and guideline recommended analgesia. Current analgesia for CS: Spinal hyperbaric bupivacaine 5 mg/ml, 9-11 mg. Spinal fentanyl 10-15 ug. Postoperative: Paracetamol 1g x 4, ibuprofen 400 mg x 4 po, oxycodone 10 mg (\<70 kg) or 20 mg (\>70 kg) x 2 po, additional oxycodone 2,5 mg iv/5 mg po when needed. Guideline recommended analgesia for CS: Spinal hyperbaric bupivacaine 5 mg/ml, 9-11 mg. Spinal fentanyl 12,5 ug. Spinal morphine 0,05 mg. After delivery of baby: Dexamethasone 8 mg iv, paracetamol 1g iv, parecoxib 40 mg iv. Postoperative: Paracetamol 1g x 4, ibuprofen 600 mg x 4 po, oxycodone 2,5 mg iv/5 mg po when needed.

Interventions

DRUGBupivacaine-fentanyl-morphine elective group

Guideline recommended analgesia in elective caesarian section.

DRUGBupivacaine-fentanyl elective group

Current analgesia in elective caesarian section.

DRUGBupivacaine-fentanyl emergency group

Current analgesia in emergency caesarian section.

Sponsors

Conrad Arnfinn Bjørshol
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Current treatment: Patients receive elective or emergency CS. Guideline recommended treatment: Only elective CS included.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

\- Healthy parturient, term pregnancy, undergoing caesarian section

Exclusion criteria

* Patient refusal * Maternal heart or lung disease (not including mild asthma) * Known or suspected obstructive sleep apnoea syndrome * Pre-eclampsia * Body mass index \> 40 * Indulin-dependent diabetes mellitus * Contraindications to ibuprofen, dexamethasone or morphine * Chronic pain * Neurological disease * Drug abuse * Age \< 18 years * American Society of Anesthesiologists (ASA) 3 * Patients receiving other forms of anaesthesia (epidural or general)

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain at maternity ward 20 hours after arrivalAt maternity ward 20 hours after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at 120 minutesAt postoperative care unit 120 minutes after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at maternity ward arrivalImmediately upon arrival at maternity wardPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at maternity ward 4 hours after arrivalAt maternity ward 4 hours after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at maternity ward 8 hours after arrivalAt maternity ward 8 hours after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at maternity ward 12 hours after arrivalAt maternity ward 12 hours after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at maternity ward 16 hours after arrivalAt maternity ward 16 hours after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at postoperative care unit arrivalImmediately upon arrival at postoperative care unitPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at 30 minutesAt postoperative care unit 30 minutes after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at 60 minutesAt postoperative care unit 60 minutes after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).
Postoperative pain at 90 minutesAt postoperative care unit 90 minutes after arrivalPostoperative pain during rest and movement measured by numeric rating scale (NRS).

Secondary

MeasureTime frameDescription
Postoperative nausea and vomiting at maternity wardDuring stay at maternity ward, estimated average 22 hoursPresent (yes/no) during stay at the maternity ward
Postoperative pruritus at postoperative care unitDuring stay at postoperative care unit, estimated average 2 hoursPresent (yes/no) during stay at the postoperative care unit
Postoperative pruritus at maternity wardDuring stay at maternity ward, estimated average 22 hoursPresent (yes/no) during stay at the maternity ward
Postoperative additional oxycodone consumption at postoperative care unitDuring stay at postoperative care unit, estimated average 2 hoursNumber of mg of oxycodone administered as additional analgetics
Postoperative additional oxycodone consumption at maternity wardDuring stay at maternity ward, estimated average 22 hoursNumber of mg of oxycodone administered as additional analgetics
Postoperative nausea and vomiting at postoperative care unitDuring stay at postoperative care unit, estimated average 2 hoursPresent (yes/no) during stay at the postoperative care unit

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026